Want to see TSE:CANB full AI Analyst Report?
Top Page
CanadaBis Capital
(CANB)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.01
▼(-30.00% Downside)
Action:Reiterated
Date:08/04/26
The score is weighed down primarily by weak financial performance—especially inconsistent and recently negative operating/free cash flow, declining revenue, and a return to net losses—raising funding and durability risks. Technicals add pressure with the stock trading below key moving averages and no strong momentum signal. Valuation does not offset these risks due to a negative P/E and no dividend data.
Positive Factors
Solid Gross Margin
A still-solid gross margin provides some underlying product economics and may help the company recover profitability if revenue stabilizes and operating costs are better controlled.
Negative Factors
Revenue Declines
Two consecutive years of declining revenue weaken visibility and suggest that prior growth has not yet become durable. Sustained contraction could reduce scale benefits and make a return to profitability more difficult.
Read all positive and negative factors
Positive Factors
Negative Factors
Solid Gross Margin
A still-solid gross margin provides some underlying product economics and may help the company recover profitability if revenue stabilizes and operating costs are better controlled.
Read all positive factors
CanadaBis Capital (CANB) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$2.07M
Dividend YieldN/A
Average Volume (3M)63.89K
Price to Earnings (P/E)―
Beta (1Y)-1.06
Revenue Growth-12.84%
EPS Growth-681.25%
CountryCA
EmployeesN/A
SectorGeneral
Sector StrengthN/A
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding138,256,380
10 Day Avg. Volume172,725
30 Day Avg. Volume63,891
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.94
Price to Sales (P/S)0.37
P/FCF Ratio-1.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CanadaBis Capital Business Overview & Revenue Model
Company Description
CanadaBis Capital Inc. is a Canadian firm specializing in the production and distribution of recreational cannabis and its extracted forms. The organization's business activities are divided into three principal divisions: Cultivation and Wholesal...
CanadaBis Capital Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
52
Neutral
Cash Flow
24
Negative
| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.90M | 17.95M | 22.22M | 11.67M | 6.87M |
| Gross Profit | 6.98M | 8.82M | 11.78M | 5.57M | 2.52M |
| EBITDA | 800.05K | 2.09M | 5.68M | 1.57M | -1.81M |
| Net Income | -835.20K | 600.28K | 4.44M | 608.33K | -2.68M |
Balance Sheet | |||||
| Total Assets | 24.54M | 24.55M | 22.96M | 15.48M | 13.28M |
| Cash, Cash Equivalents and Short-Term Investments | 831.06K | 1.68M | 3.23M | 144.88K | 849.50K |
| Total Debt | 7.75M | 6.44M | 7.31M | 7.82M | 8.44M |
| Total Liabilities | 17.83M | 16.45M | 15.62M | 12.84M | 11.46M |
| Stockholders Equity | 6.62M | 8.00M | 7.25M | 2.54M | 1.73M |
Cash Flow | |||||
| Free Cash Flow | -3.37M | -594.48K | 4.57M | -292.54K | -1.96M |
| Operating Cash Flow | -3.20M | -256.31K | 5.55M | -82.77K | -1.81M |
| Investing Cash Flow | -169.65K | -328.33K | -965.82K | -209.77K | 122.77K |
| Financing Cash Flow | 2.52M | -962.02K | -1.50M | -412.09K | 2.37M |
CanadaBis Capital Peers Comparison
UnderperformOutperform
Sector (55)
TSE:CANB
CanadaBis Capital
0.02
-0.03
-62.50%
TSE:BAMM
Body & Mind
0.03
0.00
0.00%
TSE:CVGR
City View Green Holdings
0.03
0.00
0.00%
TSE:CDVA
CordovaCann
0.05
-0.03
-37.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.